GFP Reporter Cell Line - 7721

The 7721 cell line is a well-established human hepatocellular carcinoma (HCC) model derived from liver cancer tissue. As a widely used in vitro system, it retains key characteristics of hepatocellular carcinoma, including uncontrolled proliferation, invasiveness, and specific molecular markers. This cell line is a valuable tool for studying liver cancer biology, mechanisms of tumor progression, and responses to therapeutic interventions. Researchers utilize 7721 cells to investigate gene expression patterns, signaling pathways, and drug sensitivity profiles associated with hepatocellular carcinoma, thereby linking laboratory findings to potential clinical applications.

The GFP reporter cell line – 7721 integrates green fluorescent protein (GFP) technology into the 7721 hepatocellular carcinoma model, enabling real-time visualization and quantitative analysis of cellular processes. This engineered cell line is widely used in metastasis studies to track tumor cell migration and invasion, with GFP fluorescence allowing for precise monitoring of cancer cell movement within the extracellular matrix or vascular system. In drug discovery pipelines, researchers utilize this reporter cell line to assess compound efficacy by measuring the viability or apoptotic response of GFP-labeled cells. This system also facilitates high-throughput screening of anti-cancer drugs and enables longitudinal studies of tumor growth dynamics in xenograft models using non-invasive fluorescence imaging techniques. Furthermore, scientists utilize this tool to study tumor microenvironment interactions, cancer stem cell behavior, and the effects of genetic manipulations on oncogenic pathways in living cells, significantly enhancing the capabilities of hepatocellular carcinoma research.